| # | Drug | Count |
|---|---|---|
| 0 | LEVETIRACETAM | 23 |
| 1 | LEVETIRACETAM IN SODIUM CHLORIDE | 21 |
| 2 | LEVETIRACETAM INJECTION | 21 |
| 3 | LEVETIRACETAM ORAL | 21 |
| 4 | FLUOROURACIL | 19 |
| 5 | FLUOROURACIL CREAM, 0.5% | 19 |
| 6 | PREDNISONE | 17 |
| 7 | OLANZAPINE | 13 |
| 8 | LITHIUM | 12 |
| 9 | LITHIUM BROMATUM | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ZOLBETUXIMAB | 5 | 0.0033 |
| 1 | AMPHETAMINE SULFATE TABLETS | 4 | 0.0023 |
| 2 | METHYLERGONOVINE MALEATE | 1 | 0.0016 |
| 3 | SODIUM CITRATE | 2 | 0.0016 |
| 4 | SIBEPRENLIMAB | 1 | 0.0015 |
| 5 | CHLORPROMAZINE | 9 | 0.0014 |
| 6 | GLUTATHIONE | 2 | 0.0012 |
| 7 | LITHIUM CARBONATE | 12 | 0.0007 |
| 8 | FLURBIPROFEN | 1 | 0.0007 |
| 9 | ESLICARBAZEPINE ACETATE | 2 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nucleoside Metabolic Inhibitor [EPC] | 30 |
| 1 | Atypical Antipsychotic [EPC] | 29 |
| 2 | Benzodiazepine [EPC] | 22 |
| 3 | Corticosteroid [EPC] | 22 |
| 4 | Platinum-based Drug [EPC] | 21 |
| 5 | Microtubule Inhibitor [EPC] | 12 |
| 6 | Anti-epileptic Agent [EPC] | 10 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 10 |
| 8 | Mood Stabilizer [EPC] | 10 |
| 9 | Alkylating Drug [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 5 | 0.0033 |
| 1 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 8 | 0.0004 |
| 2 | Antimetabolite Immunosuppressant [EPC] | 6 | 0.0003 |
| 3 | Typical Antipsychotic [EPC] | 4 | 0.0002 |
| 4 | Melatonin Receptor Agonist [EPC] | 2 | 0.0002 |
| 5 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 1 | 0.0001 |
| 6 | Topoisomerase Inhibitor [EPC] | 9 | 0.0001 |
| 7 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 30 | 0.0001 |
| 9 | Central Nervous System Stimulant [EPC] | 8 | 0.0001 |